Evidence map›Paper›PMID 33327641›Full record

ArticleInternational journal of environmental research and public health2020

Persistence of COVID-19 Symptoms after Recovery in Mexican Population.

Carlos E Galván-Tejada, Cintya Fabiola Herrera-García, Susana Godina-González, Karen E Villagrana-Bañuelos, Juan Daniel De Luna Amaro, Karla Herrera-García, Carolina Rodríguez-Quiñones, Laura A Zanella-Calzada, Julio Ramírez-Barranco, Jocelyn L Ruiz de Avila and 8 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2022
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Recovery Patterns of COVID-19 Related Smell Disorders: An Analysis of the Available Evidence.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. What might COVID-19 patients experience after recovery? A comprehensive review.The International journal of pharmacy practice · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Carlos E Galván-TejadaUnidad Académica de Ingeniería Eléctrica, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.ORCID 0000-0002-7635-4687
Cintya Fabiola Herrera-GarcíaUnidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.
Susana Godina-GonzálezUnidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.ORCID 0000-0003-0340-9381
Karen E Villagrana-BañuelosUnidad Académica de Ingeniería Eléctrica, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.ORCID 0000-0002-0684-6483
Juan Daniel De Luna AmaroHospital General de Jerez, Zacatecas 99390, Mexico.ORCID 0000-0002-4455-8474
Karla Herrera-GarcíaUnidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.
Carolina Rodríguez-QuiñonesUnidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.
Laura A Zanella-CalzadaLORIA (INRIA, CNRS, Université de Lorraine), Campus Scientifique BP 239, 54506 Nancy, France.ORCID 0000-0002-8049-8077
Julio Ramírez-BarrancoEpidemiología y Medicina Preventiva, ISSSTE, Gpe. Zacatecas 98613, Mexico.
Jocelyn L Ruiz de AvilaFacultad de Medicina, Centro de Investigación en Ciencias de la Salud y Biomedicina (CICSaB), Universidad Autónoma de San Luis Potosí, San Luis Potosí 78300, Mexico.
Fuensanta Reyes-EscobedoUnidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.
José M Celaya-PadillaUnidad Académica de Ingeniería Eléctrica, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.ORCID 0000-0001-6847-3777
Jorge I Galván-TejadaUnidad Académica de Ingeniería Eléctrica, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.
Hamurabi Gamboa-RosalesUnidad Académica de Ingeniería Eléctrica, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.ORCID 0000-0002-9498-6602
Mónica Martínez-AcuñaUnidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.ORCID 0000-0001-6084-5986
Alberto Cervantes-VillagranaUnidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.ORCID 0000-0001-7344-353X
Bruno Rivas-SantiagoUnidad de Investigación Biomédica de Zacatecas, IMSS, Zacatecas 98000, Mexico.
Irma E Gonzalez-CurielUnidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.ORCID 0000-0002-0044-9196

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19.

Indexed as

AdultCase-Control StudiesChronic DiseaseCOVID-19FemaleHumansMaleMexicoMiddle AgedSurveys and QuestionnairesCOVID-19persistent symptomspost-COVID syndromerecovered from COVIDSARS-CoV-2

Identifiers

PMID33327641
PMCPMC7765113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.